[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
[ Mon, Apr 24th 2023 ]: WOPRAI
Jayson Bedford Downgraded (TNDM) to Hold on, Apr 24th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Jayson Bedford of Raymond James, Downgraded "Tandem Diabetes Care, Inc." (TNDM) to Hold on, Apr 24th, 2023.
Jayson has made no other calls on TNDM in the last 4 months.
There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 3 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Danielle Antalffy of "UBS" Initiated at Hold and Held Target at $45 on, Wednesday, March 29th, 2023
- Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $40 on, Thursday, February 23rd, 2023
- Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023
These are the ratings of the 2 analyists that currently disagree with Jayson
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023